chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, muscle aches, chills, weekness, exhaustion.  Started about 6 hours after shot, lasted for 224 hours.
Information has been received from a 50 year old female nurse, with asthma and penicillin allergy and a history of splenectomy, who on 2/6/06 was vaccinated in her left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650453/0791P). On 2/6/06, within 1 minute of receiving the vaccination in her left arm she began to experience an adverse reaction. She reported that her throat started to close, and she developed a cough. She stated her "chest closed up" and she had a pain in her left shoulder blade. Her face turned red. The reaction started to subside and then she developed chest pain and tachycardia. Her tongue felt swollen. Her eyes were blurry and her head felt wobbly. She also had a slight chest rash and itching. She also had chills. She was given fexofenadine hydrochloride in the office and the symptoms subsided. She then took diphenhydramine when she got home. About three hours later she still had a little chest tightness and a fast heart rate. No lab diagnostic studies were performed. On 2/7/06 the patient recovered. No product quality complaint was involved. She also reported that when she received pneumococcal 23v polysaccharide vaccine in 2001, she had arm swelling with a red spot at the injection site. Throat started to close, a cough, "chest closed up", pain in her left shoulder blade, face turned red, chest pain, tachycardia, tongue felt swollen, eyes were blurry, head felt wobbly, chest rash, itching, chills, arm swelling and red spot at the injection site were considered to be other important medical events (OMIC). Additional information has been requested.
recurrent cystitis, falls, leukocytosis, pain to finger, hip, shoulder because of falls
A nurse reported the occurrence of injection site cellulitis in a 25-month-old female who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). The pt's medical history, concurrent conditions and concurrent medications were not specified. On 09/23/2002, the pt received her 4th injection of Infanrix. 24 hours later, the pt developed swelling of the leg. 72 hours post-immunization, the pt developed injection site cellulitis and swollen eyes. The reporter considered the events to be related to Infanrix administration. Comment: This report has been linked to reports A0382391A, A0386782A, A0386784A and A0386785A due to same reporter.
he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing; he had high fevers as well/his fever was 103F; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) and PYREXIA (he had high fevers as well/his fever was 103F) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020 and Mechanical ventilation in 2020.    On 02-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) and PYREXIA (he had high fevers as well/his fever was 103F). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Fever, at an unspecified dose and frequency and METHOCARBAMOL (ROBAXIN) for Adverse event, at an unspecified dose and frequency. On 03-Sep-2021, PYREXIA (he had high fevers as well/his fever was 103F) had resolved. At the time of the report, MYALGIA (he is complaining of lots of muscle pain/the muscle ache is moderate/muscle ache is still ongoing) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, Body temperature: 103 (High) 103  F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter It was reported that the patient was a healthy person with no comorbidities and he exercise regularly He had infected with COVID 19 and nearly lost his life as he was on ventilator His wife reported that he had a natural immunity against the virus   Most recent FOLLOW-UP information incorporated above includes: On 09-Sep-2021: Follow-up contains lot number updated.
No adverse event.  Medical Director was notified. Family is aware. Patient given wrong dose of Pfizer Biotech, patient given Pfizer Biotech 12 and up.
This spontaneous report as received from an office manager refers to a male patient of unknown age. The patient was vaccinated with a dose of CERVARIX on 14-JUN-2012. On 16-JUL-2012, the patient was vaccinated with a dose of GARDASIL (vaccination site unknown), lot number not reported. No adverse effect reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
cellulitis was developed belowher injection site which is 3-5 inches in size; Fever 99.7 F; mild headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of CELLULITIS (cellulitis was developed belowher injection site which is 3-5 inches in size) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced CELLULITIS (cellulitis was developed belowher injection site which is 3-5 inches in size) (seriousness criterion medically significant). In April 2021, the patient experienced PYREXIA (Fever 99.7 F) and HEADACHE (mild headache). At the time of the report, CELLULITIS (cellulitis was developed belowher injection site which is 3-5 inches in size) was resolving and PYREXIA (Fever 99.7 F) and HEADACHE (mild headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 99.7.         The patient was taking unspecified concomitant medication. The patient visited her Doctor's office and started treatment which her MD prescribed sulfamethoxazole oral antibiotic, and mupirocin 2% Ointment. Action taken with mRNA-1273 in response to events was not applicable. Treatment included Sulfamethoxaz and topical ointment. Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Reporter details, event (fever 99.7) and treatment medications were updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Information has been received from a nursing supervisor concerning a female (age not reported) who on an unspecified date was vaccinated with HPV. Subsequently, the patient reported that her "arm felt dead". At the time of this report, the outcome of the event was unknown. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Initial and follow up information has been received from a nursing supervisor concerning an 18 year old female who at 11:30am, on 14-DEC-2006 was vaccinated in the left deltoid with the first dose of GARDASIL (Lot # 654389/0961F). Subsequently, the patient reported she felt it go all down her arm during the vaccination, and stated her "arm felt heavy all day long" (previously reported as "felt dead"). In follow up information, the nurse reported that, as the patient was leaving the facility she fainted and "was out for a few seconds". The nurse took the patient's vital signs and gave her juice, and reported "she was fine". The outcome of the events was unknown. It was unknown if the patient recovered from feeling the vaccine go down her arm and the feeling of arm heaviness. Additional information is not expected.
Flu shot 7:45 Wednesday morning. Left arm & right arm. Pneumovax and flu. Not sure which vaccine she received in which arm.  10cm X 8cm erythema to left deltoid aspect.
A physician reported that a 59 year old female received an injection of Pnu-Imune 23. On 09/27/00, she developed an injection site reaction characterized by a large red welt, swelling, heat, and achiness.
On Sat March 18 I felt like I was having some head congestion and some fatigue, and I didn't think it was COVID-19. The next day I started to have body aches and fever and that when I figured it was more than just a head cold. I tested for COVID-19 and was positive the following day I went to the local clinic to confirm that I had COVID-19. I was in fact correct that I was positive for COVID-19. I was given a prescription for PAXLOVID. From March 20-24, I started to recover and had zero symptoms left. I took another home test on March 26 I was positive and then again, the next day and was negative. A few days later I tested again and was negative and the only symptoms that I had left were the allergy like symptoms.
This spontaneous report as received from a medical assistant refers to a 6-year-old male patient. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies were provided. On 26-SEP-2018, the patient was vaccinated with VAQTA lot # N017094, expiration date 31-AUG-2018, intramuscular, for prophylaxis (dose number was not provided). It was reported that VAQTA was expired at the time of administration. There was no adverse event reported. The outcome of expired product administered was not provided.
pt recv vax 1APR97 & 9APR97 pt exp t104;10APR97 pt devel rash consisting of papules on trunk, face & extremities consisting of 100 lesions;lesion had small vesicle forming in the center of papules;
Post vax, the patient leg showed redness in an intermittent pattern with some swelling in an area about 10".
Red blister like area "size of pencil eraser" left arm according to pt. rash on neck, trunk and abdomen. Lymph node enlarged below left ear according to pt.. 09/03/2002 PC to mom, pt doing better, going to school and work, Did not see PMD
Information has been received from a licensed visiting nurse concerning a greater than 12 week old patient who on 29 Nov 2006 was vaccinated with a first oral dose of Rotateq (human bovine) (Lot#654663/0942F). It was noted that the patient was not experiencing any known symptoms. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
7/22/16 vaccines administered at 12 mo WCC. 7/31/16 developed rash, started on neck seen in office 8/22/16 rash covering all surfaces.
Information has been received which reported that a 4 year old male patient with none pre-existing allergies, birth defects or medical conditions and red arm and swelling at the time of vaccination, who on 18-MAR-2010 at 8:00 a.m. was vaccinated with a second dose of MMR II in the left deltoid (route unspecified and lot number: 664606/0617Y), a second dose of VARIVAX (Merck) in the right deltoid (route unspecified and lot number: 664614/0970Y) and a fifth dose of KINRIX, on the same day, at 08:00 in the left deltoid (route unspecified and lot number:AC20B13BAA). On 18-MAR-2010 at 08:00, the health professional reported that the patient's left arm was red and swollen. The patient visited the emergency room and was given with antibiotics. At the time of the report, the outcome of the patient was recovered on 31-MAR-2010. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a 75 year old female. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 14-MAY-2014, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On or about 06-MAR-2017, the patient was treated by a by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Has been sick with sore throat but feeling beter when she got her flu shot. Left arm is swollen. Pt noted reddened area about 2 inches in diameter. Warm to touch. Pt states she feels a little feverish. Arm is uncomfortable.
This spontaneous medically confirmed report (initial receipt 25-Nov-2014) concerns a patient. On an unspecified date, the patient received AFLURIA (batch number not reported). On an unspecified date, the patient experienced anaphylactic reaction. Outcome was not reported.
The vaccine was given subcutaneously instead of intramuscularly in error. The patient did not report any adverse effects, but this was noticed at pharmacy level.
This case was reported by a pharmacist via call center representative and described the occurrence of headache in a elderly female patient who received SHINGRIX (batch number H7JY4, expiry date 1st July 2021) for prophylaxis. Concurrent medical conditions included drug allergy (unspecified). On 1st March 2019, the patient received SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced headache, chills, fever, diarrhea, pain, injection site redness, prickly heat, injection site warmth and reactogenicity event. On an unknown date, the outcome of the headache, chills, fever, diarrhea, pain, injection site redness, prickly heat, injection site warmth and reactogenicity event were unknown. It was unknown if the reporter considered the headache, chills, fever, diarrhea, pain, injection site redness, prickly heat, injection site warmth and reactogenicity event to be related to SHINGRIX. Additional details were provided as follows: The patient was very sensitive to medications and had high reactogenicity (unspecified).
About 12 hours after the vaccine at night. Fatigue came first and then the body aches and chills. The chills caused severe shivering that hurt and felt as if I had a high temperature when that was not true. I took a 1-2 500mg Tylenol every 4-6 hours. My temperature when chills were so bad was taken even when I had not taken any medication and did not reach a dangerously high level. Tylenol seemed to have little effect on the shakes and muscle aches. I weigh 100 pounds. A 1000mg of Tylenol usually works. Temperature was taken through the night about 3 hour intervals and did not reach above 100.1 F. However the chills and shakes were rough and lasted only about another 12 hours. Throughout the next day I felt severe fatigue as if I?ve had high fever but the fever has subsided within the same time period as the chills. That night (a little after 24 hours) I sweated enough to drench the sheets at night time. By around 32-36 hours after the vaccine I felt better maybe still a little tired. I wanted to report this symptoms because I had a tetnus booster 16 days prior to the vaccine. I wanted to not make an assumption but an observation that the chills cause such shivers that my muscles felt almost as if they were becoming fatigued from being tense for so long. Similar to how tetnus resides. Just an observation and to report as a good cause and effect. I have since a month later going to get my second vaccine soon have not yet seen any other adverse reaction.
Information has been received from a physician concerning a patient who was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). One day post vaccination with HPV rL1 6 11 16 18 VLP vaccine (yeast, the patient developed facial palsy (not further specified). The patient outcome was not reported. Additional information is not expected.
This case was reported by a consumer via call center representative and described the occurrence of multiple sclerosis in a male patient who received ENGERIX B. On an unknown date, the patient received the 3rd dose of ENGERIX B. On an unknown date, less than a month after receiving ENGERIX B, the patient experienced multiple sclerosis (serious criteria GSK medically significant), muscle twitching, mental distress, itchy legs, hair loss, joint injury and connective tissue disorder. On an unknown date, the outcome of the multiple sclerosis, muscle twitching, mental distress, itchy legs, hair loss and joint injury were unknown and the outcome of the connective tissue disorder was not recovered/not resolved. It was unknown if the reporter considered the multiple sclerosis, muscle twitching and mental distress to be related to ENGERIX B. The reporter considered the itchy legs, hair loss, joint injury and connective tissue disorder to be related to ENGERIX B. Additional details were provided as follows: The patient refused to provide his name and demographics. He stated he had already reported these issues to Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Vaccine Adverse Event Reporting System (VAERS) and his physician. The age at vaccination was not reported. The patient had received all 3 doses of the vaccine in his left arm and had experienced muscle twitching in his left arm since then. The patient stated that he experienced these issues along with others (not named) within a month of the 3rd vaccine and he has been suffering for more than 3 years at the time of reporting. The patient stated that his physician might have reported it to GlaxoSmithKline also, as his physician contacted GlaxoSmithKline himself. The patient noted but was not able to confirm a possible Human leukocyte antigen (HLA) B27 gene marker, as he was investigating these symptoms and possible multiple sclerosis. The patient noted that he had been researching this for the last 12 months. He stated he was upset that GlaxoSmithKline was not doing anything to help him, as the vaccine had harmed him and the burden of proof was on him to determine the causality of his injuries and the vaccine. The patient stated that he has been told by his physician to consult another physician and that his physician was only offered the product information (PI) from GlaxoSmithKline when he called. He noted that he was pursuing the Vaccine Injury court for seeking legal advice and was advised not to provide any additional information to GlaxoSmithKline. The patient refused to provide his physician's name or contact information. He did not provide his phone number but called from some other number, if able to correlate to a possible previous report.
The second Moderna shot was given on Feb. 2, 2021 (16:26)  (Lot number 028220A), upper right arm,  and was followed by a slight fever and tiredness the next day.  Exactly two weeks later, Feb. 21 I experienced a severe bout of vertigo, which left me unable to stand, with continued vomiting and severe tinnitus.  I have never had anything near this extreme in my history with Meniere?s.  It lasted about an hour. The tinnitus remained at a reduced level but the vertigo was down to occasional dizziness.  A week later I had another episode of severe vertigo which lasted about 4 hours and was accompanied by severe tinnitus.   I got in to see my PCP?s nurse practitioner, March 1.  He prescribed Odansetron, 4 mg, to be taken as needed and Meclizine 25mg as needed.  I took these two pills on some days twice a day.  For the next 4-5 weeks I had the following cycle: one bad day (severe tinnitus, some vertigo) followed by a good day (tinnitus down, no vertigo) followed by increasing symptoms until day 5 or 6 of the cycle then another bad day.  This cycle continued until I found an ENT who had experience with Meniere?s. This visit was April 13, 2021.   He prescribed Diamox (Acetazolamide), 125 mg twice a day to reduce the pressure in my middle and inner ear.  The cycles stopped and I have had varying levels of relief of symptoms since then (very little dizziness, some to moderate tinnitus.  I have had about a 75% hearing loss in my left ear. Symptoms persist to some degree and when I attempt to stop the Diamox they recur at varying levels.
tachycardia; chest pain; vertigo; several other issues after the second dose of the Moderna Covid vaccine; extreme fatigue; This spontaneous case was reported by a physician and describes the occurrence of TACHYCARDIA (tachycardia), CHEST PAIN (chest pain), VERTIGO (vertigo), VACCINATION COMPLICATION (several other issues after the second dose of the Moderna Covid vaccine) and FATIGUE (extreme fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (tachycardia), CHEST PAIN (chest pain), VERTIGO (vertigo), VACCINATION COMPLICATION (several other issues after the second dose of the Moderna Covid vaccine) and FATIGUE (extreme fatigue). At the time of the report, TACHYCARDIA (tachycardia), CHEST PAIN (chest pain), VERTIGO (vertigo), VACCINATION COMPLICATION (several other issues after the second dose of the Moderna Covid vaccine) and FATIGUE (extreme fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drug information was provided.
Facial swelling, droop, numbness, tingling in left side of face. Then on 8/07/16 @ 11AM - Same thing but on right side of face.
Nausea, dizziness, sweating. Pt went to hospital ER at 1:00 AM.
Parent reports injection site swollen, red, and hot from shoulder to elbow. Red for over 30 days. Extreme irritability.
On 10/1/21 I got the flu shot at High School. 1.5 weeks later I had debilitating left chest pain where I felt crippled. It last for about 3 days. I felt it on and off but did not get treatment.  I then received the Pzifer vaccine and 3 weeks after the 2nd one I had the same pain. I went to the doctor and said I had all of the symptoms of myo or peri-carditis. Doctor didn't think it was that and ordered XRays for that day and a Echocardiogram 2 weeks later (first available appt). Results showed very mild enlarged heart but nothing major.  I know it was from the vaccines. My heart rate was 35-36 at the time of the tests. I am very healthy and physically fit. The only thing that the chest pain could be from is from the vaccines, both the flu shot Oct. 2020 and the Pfizer Covid vac 4/2021.
localized reaction at vaccine site. Mild induration with quarter sized area of erythema. and a second nickel sized area of erythema superior to site